Continuous improvements in perinatal care have allowed the survival of ever more premature infants, making the task of protecting the extremely immature lung from injury increasingly challenging. Premature infants at risk of developing chronic lung disease or bronchopulmonary dysplasia (BPD) are now born at the late canalicular stage of lung development, just when the airways become juxtaposed to the lung vasculature and when gas-exchange becomes possible. Readily available strategies, including improved antenatal management (education, regionalization, steroids, and antibiotics), together with exogenous surfactant and exclusive/early noninvasive ventilatory support, will likely decrease the incidence/severity of BPD over the next few years. Nonetheless, because of the extreme immaturity of the developing lung, the extent to which disruption of lung growth after prematurity and neonatal management lead to an earlier or more aggravated decline in respiratory function in later life is a matter of concern. Consequently, much more needs to be learned about the mechanisms of lung development, injury, and repair. Recent insight into stem cell biology has sparked interest for stem cells to repair damaged organs. This review summarizes the exciting potential of stem cell-based therapies for lung diseases in general and BPD in particular. Antioxid. Redox Signal. 17, 1013–1040.
AdamsonIY, BowdenDH. The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab Invest, 30:35–42. 1974.
3.
AfsharS, GibsonLL, YuhannaIS, ShermanTS, KerecmanJD, GrubbPH, YoderBA, McCurninDC, ShaulPW. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol, 284:L749–L758. 2003.
4.
AgostiniC. Stem cell therapy for chronic lung diseases: hope and reality. Respir Med, 104,Suppl 1:S86–S91. 2010.
5.
AguilarS, ScottonCJ, McNultyK, NyeE, StampG, LaurentG, BonnetD, JanesSM. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One, 4:e8013. 2009.
6.
AlbertineKH, JonesGP, StarcherBC, BohnsackJF, DavisPL, ChoSC, CarltonDP, BlandRD. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med, 159:945–958. 1999.
7.
AllisonBJ, CrossleyKJ, FlecknoeSJ, DavisPG, MorleyCJ, HardingR, HooperSB. Ventilation of the very immature lung in utero induces injury and BPD-like changes in lung structure in fetal sheep. Pediatr Res, 64:387–392. 2008.
8.
AlphonseR, VadivelA, WaszakP, ColtanL, FungM, EatonF, YoderMC, ThébaudB. Existence, functional impairment and therapeutic potential of endothelial colony forming cells (ECFCs) in oxygen-induced arrested alveolar growth. Am J Respir Crit Care Med, 183:A1237. 2011.
9.
AltiokO, YasumatsuR, Bingol-KarakocG, RieseRJ, StahlmanMT, DwyerW, PierceRA, BrommeD, WeberE, CataltepeS. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med, 173:318–326. 2006.
10.
AmbalavananN, NovakZE. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Pediatr Res, 53:240–244. 2003.
11.
AsikainenTM, WhiteCW. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal, 6:155–167. 2004.
12.
AskieLM, BallardRA, CutterGR, DaniC, ElbourneD, FieldD, HascoetJM, HibbsAM, KinsellaJP, MercierJC, RichW, SchreiberMD, WongsiridejPS, SubhedarNV, Van MeursKP, VoyseyM, BarringtonK, EhrenkranzRA, FinerNN. Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics, 128:729–739. 2011.
AskieLM, Henderson-SmartDJ, IrwigL, SimpsonJM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med, 349:959–967. 2003.
15.
AslamM, BavejaR, LiangOD, Fernandez-GonzalezA, LeeC, MitsialisSA, KourembanasS. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med, 180:1122–1130. 2009.
16.
AutenRL, DavisJM. Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res, 66:121–127. 2009.
17.
AutenRL, WhortonMH, Nicholas MasonS. Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. Am J Respir Cell Mol Biol, 26:391–397. 2002.
BakerCD, RyanSL, IngramDA, SeedorfGJ, AbmanSH, BalasubramaniamV. Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med, 180:454–461. 2009.
20.
BalasubramaniamV, MervisCF, MaxeyAM, MarkhamNE, AbmanSH. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol, 292:L1073–L1084. 2007.
21.
BalasubramaniamV, RyanSL, SeedorfGJ, RothEV, HeumannTR, YoderMC, IngramDA, HoganCJ, MarkhamNE, AbmanSH. Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. Am J Physiol Lung Cell Mol Physiol, 298:L315–L323. 2010.
22.
BalasubramaniamV, TangJR, MaxeyA, PlopperCG, AbmanSH. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol, 284:L964–L971. 2003.
23.
BallardPL, TruogWE, MerrillJD, GowA, PosenchegM, GolombekSG, PartonLA, LuanX, CnaanA, BallardRA. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics, 121:555–561. 2008.
BaraldiE, CarraroS, FilipponeM. Bronchopulmonary dysplasia: definitions and long-term respiratory outcome. Early Hum Dev, 85:S1–S3. 2009.
26.
BaydasG, KaratasF, GursuMF, BozkurtHA, IlhanN, YasarA, CanatanH. Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status. Arch Med Res, 33:276–280. 2002.
27.
BeltekiG, KempsterSL, ForheadAJ, GiussaniDA, FowdenAL, CurleyA, Charnock-JonesDS, SmithGC. Paraoxonase-3, a putative circulating antioxidant, is systemically up-regulated in late gestation in the fetal rat, sheep, and human. J Clin Endocrinol Metab, 95:3798–3805. 2010.
28.
BergerAC, TangG, AlexanderHR, LibuttiSK. Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis. J Immunother, 23:519–527. 2000.
29.
BergerTM, FreiB, RifaiN, AveryME, SuhJ, YoderBA, CoalsonJJ. Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study. Pediatr Res, 43:719–726. 1998.
30.
BertoncelloI, McQualterJL. Endogenous lung stem cells: what is their potential for use in regenerative medicine?Expert Rev Respir Med, 4:349–362. 2010.
31.
BhattAJ, PryhuberGS, HuyckH, WatkinsRH, MetlayLA, ManiscalcoWM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med, 164:1971–1980. 2001.
32.
BiniwaleMA, EhrenkranzRA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol, 30:200–208. 2006.
33.
BlaisdellCJ, GailDB, NabelEG. National Heart, Lung, and Blood Institute perspective: lung progenitor and stem cells—gaps in knowledge and future opportunities. Stem Cells, 27:2263–2270. 2009.
34.
BlandRD, AlbertineKH, CarltonDP, MacRitchieAJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med, 172:899–906. 2005.
35.
BlandRD, ErtseyR, MokresLM, XuL, JacobsonBE, JiangS, AlviraCM, RabinovitchM, ShinwellES, DixitA. Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice. Prelude to defective alveolar septation during lung development?Am J Physiol Lung Cell Mol Physiol, 294:L3–L14. 2008.
36.
BlauHM, BrazeltonTR, WeimannJM. The evolving concept of a stem cell: entity or function?Cell, 105:829–841. 2001.
37.
BlumB, BenvenistyN. The tumorigenicity of human embryonic stem cells. Adv Cancer Res, 100:133–158. 2008.
38.
Bonnefont-RousselotD, CollinF. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology, 278:55–67. 2010.
39.
BorghesiA, MassaM, CampanelliR, BollaniL, TziallaC, FigarTA, FerrariG, BonettiE, ChiesaG, de SilvestriA, SpinilloA, RostiV, StronatiM. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med, 180:540–546. 2009.
40.
BorthwickDW, ShahbazianM, KrantzQT, DorinJR, RandellSH. Evidence for stem-cell niches in the tracheal epithelium. Am J Respir Cell Mol Biol, 24:662–670. 2001.
41.
BostromH, WillettsK, PeknyM, LeveenP, LindahlP, HedstrandH, PeknaM, HellstromM, Gebre-MedhinS, SchallingM, NilssonM, KurlandS, TornellJ, HeathJK, BetsholtzC. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell, 85:863–873. 1996.
42.
BourbonJ, BoucheratO, Chailley-HeuB, DelacourtC. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res, 57:38R–46R. 2005.
43.
BrettellLM, McGowanSE. Basic fibroblast growth factor decreases elastin production by neonatal rat lung fibroblasts. Am J Respir Cell Mol Biol, 10:306–315. 1994.
44.
BrionLP, BellEF, RaghuveerTS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev, CD003665. 2003.
BryK, HogmalmA, BackstromE. Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia. Semin Perinatol, 34:211–221. 2010.
47.
BuckleyS, ShiW, CarraroG, SedrakyanS, Da SaccoS, DriscollBA, PerinL, de FilippoRE, WarburtonD. The milieu of damaged AEC2 stimulates alveolar wound repair by endogenous and exogenous progenitors. Am J Respir Cell Mol Biol, 45:1212–1221. 2011.
48.
BuckleyS, WarburtonD. Dynamics of metalloproteinase-2 and −9, TGF-beta, and uPA activities during normoxic vs. hyperoxic alveolarization. Am J Physiol Lung Cell Mol Physiol, 283:L747–754. 2002.
49.
BurnhamEL, TaylorWR, QuyyumiAA, RojasM, BrighamKL, MossM. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med, 172:854–860. 2005.
50.
BurriPH. Structural aspect of prenatal and postnatal development and growth of the lung. Lung Growth and Development. McDonaldJA.New York: Marcel Dekker, 1997; 1–35.
51.
CapoluongoE, AmeglioF, ZuppiC. Insulin-like growth factor-I and complications of prematurity: a focus on bronchopulmonary dysplasia. Clin Chem Lab Med, 46:1061–1066. 2008.
52.
CarraroG, PerinL, SedrakyanS, GiulianiS, TiozzoC, LeeJ, TurcatelG, De LangheSP, DriscollB, BellusciS, MinooP, AtalaA, De FilippoRE, WarburtonD. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells, 26:2902–2911. 2008.
53.
CernyL, TordayJS, RehanVK. Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung, 186:75–89. 2008.
54.
Chailley-HeuB, BoucheratO, Barlier-MurA-M, BourbonJR. FGF-18 is upregulated in the postnatal rat lung and enhances elastogenesis in myofibroblasts. Am J Physiol Lung Cell Mol Physiol, 288:L43–L51. 2005.
ChettyA, AnderssonS, LassusP, NielsenHC. Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD. Pediatr Pulmonol, 37:128–136. 2004.
57.
ChoK-S, ParkH-K, ParkH-Y, JungJS, JeonS-G, KimY-K, RohHJ. IFATS collection: immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells, 27:259–265. 2009.
58.
CiccocioppoR, BernardoME, SgarellaA, MaccarioR, AvanziniMA, UbezioC, MinelliA, AlvisiC, VanoliA, CalliadaF, DionigiP, PerottiC, LocatelliF, CorazzaGR. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut, 60:788–798. 2011.
59.
CoalsonJJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol, 8:73–81. 2003.
60.
CoalsonJJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol, 30:179–184. 2006.
61.
CoalsonJJ, WinterVT, Siler-KhodrT, YoderBA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med, 160:1333–1346. 1999.
62.
CompernolleV, BrusselmansK, AckerT, HoetP, TjwaM, BeckH, PlaisanceS, DorY, KeshetE, LupuF, NemeryB, DewerchinM, Van VeldhovenP, PlateK, MoonsL, CollenD, CarmelietP. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med, 8:702–710. 2002.
63.
CouroucliXI, LiangYW, JiangW, BarriosR, MoorthyB. Attenuation of oxygen-induced abnormal lung maturation in rats by retinoic acid: possible role of cytochrome P4501A enzymes. J Pharmacol Exp Ther, 317:946–954. 2006.
64.
D'AngioCT, ManiscalcoWM. The role of vascular growth factors in hyperoxia-induced injury to the developing lung. Front Biosci, 7:d1609–d1623. 2002.
65.
DaleyGQ. Stem cells: roadmap to the clinic. J Clin Invest, 120:8–10. 2010.
66.
DammannCE, NielsenHC, CarrawayKL3rd.Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med, 167:1711–1716. 2003.
67.
DananC, JarreauP-H, FrancoM-L, DassieuG, GrillonC, Abd AlsamadI, LafumaC, HarfA, DelacourtC. Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol, 283:L1086–L1093. 2002.
68.
DarlowBA, AustinNC. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev, CD003312. 2003.
69.
DavdaJ, LabhasetwarV. An update on angiogenesis therapy. Crit Rev Eukaryot Gene Expr, 11:1–21. 2001.
70.
DavisJM, AutenRL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med, 15:191–195. 2010.
71.
DavisJM, ParadRB, MicheleT, AllredE, PriceA, RosenfeldW. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics, 111:469–476. 2003.
72.
De PaepeME, MaoQ, GhantaS, HovanesianV, PadburyJF. Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells. Am J Pathol, 178:1329–1339. 2011.
73.
This reference has been deleted.
74.
DebierC, LarondelleY. Vitamins A and E: metabolism, roles and transfer to offspring. Br J Nutr, 93:153–174. 2005.
75.
DobbsLG, JohnsonMD, VanderbiltJ, AllenL, GonzalezR. The great big alveolar TI cell: evolving concepts and paradigms. Cell Physiol Biochem, 25:55–62. 2010.
76.
DoveyJS, ZacharekSJ, KimCF, LeesJA. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci U S A, 105:11857–11862. 2008.
77.
DriscollB, BuckleyS, BuiKC, AndersonKD, WarburtonD. Telomerase in alveolar epithelial development and repair. Am J Physiol Lung Cell Mol Physiol, 279:L1191–L1198. 2000.
78.
DulakJ, JozkowiczA. Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal, 5:123–132. 2003.
79.
EkekezieII, ThibeaultDW, SimonSD, NorbergM, MerrillJD, BallardRA, BallardPL, TruogWE. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics, 113:1709–1714. 2004.
80.
FadiniGP, AvogaroA, AgostiniC. Pathophysiology of circulating progenitor cells in pulmonary disease and parallels with cardiovascular disease. Am J Respir Cell Mol Biol, 35:403–404. 2006.
81.
FawkeJ, LumS, KirkbyJ, HennessyE, MarlowN, RowellV, ThomasS, StocksJ. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med, 182:237–245. 2010.
82.
FehrenbachH. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res, 2:33–46. 2001.
83.
FigliuzziM, CornoltiR, PericoN, RotaC, MorigiM, RemuzziG, RemuzziA, BenigniA. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. Transplant Proc, 41:1797–1800. 2009.
84.
FinerNN, CarloWA, WalshMC, RichW, GantzMG, LaptookAR, YoderBA, FaixRG, DasA, PooleWK, DonovanEF, NewmanNS, AmbalavananN, FrantzID3rd, BuchterS, SanchezPJ, KennedyKA, LaroiaN, PoindexterBB, CottenCM, Van MeursKP, DuaraS, NarendranV, SoodBG, O'SheaTM, BellEF, BhandariV, WatterbergKL, HigginsRD. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med, 362:1970–1979. 2010.
85.
FriedensteinAJ, ChailakhjanRK, LalykinaKS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet, 3:393–403. 1970.
86.
FritzellJA, MaoQ, GundavarapuS, PasquarielloT, AliottaJM, AyalaA, PadburyJF, De PaepeME. Fate and effects of adult bone marrow cells in lungs of normoxic and hyperoxic newborn mice. Am J Respir Cell Mol Biol, 40:575–587. 2009.
87.
GahrtonG, BjörkstrandB. Progress in haematopoietic stem cell transplantation for multiple myeloma. J Intern Med, 248:185–201. 2000.
88.
GalambosC, NgYS, AliA, NoguchiA, LovejoyS, D'AmorePA, DeMelloDE. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am J Respir Cell Mol Biol, 27:194–203. 2002.
89.
GauldieJ, GaltT, BonniaudP, RobbinsC, KellyM, WarburtonD. Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol, 163:2575–2584. 2003.
90.
GiangrecoA, ReynoldsSD, StrippBR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol, 161:173–182. 2002.
91.
GienJ, KinsellaJP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr, 23:305–313. 2011.
92.
GonzalezRF, AllenL, DobbsLG. Rat alveolar type I cells proliferate, express OCT-4, and exhibit phenotypic plasticity in vitro. Am J Physiol Lung Cell Mol Physiol, 297:L1045–L1055. 2009.
93.
GriffithsMJ, BonnetD, JanesSM. Stem cells of the alveolar epithelium. Lancet, 366:249–260. 2005.
94.
GuptaN, SuX, PopovB, LeeJW, SerikovV, MatthayMA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol, 179:1855–1863. 2007.
95.
HallSM, HislopAA, PierceCM, HaworthSG. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. Am J Respir Cell Mol Biol, 23:194–203. 2000.
96.
HanRN, StewartDJ. Defective lung vascular development in endothelial nitric oxide synthase-deficient mice. Trends Cardiovasc Med, 16:29–34. 2006.
97.
HansenAR, BarnesCM, FolkmanJ, McElrathTF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr, 156:532–536. 2010.
98.
HareJM, TraverseJH, HenryTD, DibN, StrumpfRK, SchulmanSP, GerstenblithG, DeMariaAN, DenktasAE, GammonRS, HermillerJBJr., ReismanMA, SchaerGL, ShermanW. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol, 54:2277–2286. 2009.
99.
HatoT, KimuraY, MorisadaT, KohGY, MiyataK, TabataM, KadomatsuT, EndoM, UranoT, AraiF, ArakiK, SudaT, KobayashiK, OikeY. Angiopoietins contribute to lung development by regulating pulmonary vascular network formation. Biochem Biophys Res Commun, 381:218–223. 2009.
100.
HayWWJr.and Bell EF. Oxygen therapy, oxygen toxicity, and the STOP-ROP trial. Pediatrics, 105:424–425. 2000.
101.
HegabAE, KuboH, FujinoN, SuzukiT, HeM, KatoH, YamayaM. Isolation and characterization of murine multipotent lung stem cells. Stem Cells Dev, 19:523–536. 2010.
102.
HegemanMA, HennusMP, van MeursM, CobelensPM, KavelaarsA, JansenNJ, SchultzMJ, van VughtAJ, MolemaG, HeijnenCJ. Angiopoietin-1 treatment reduces inflammation but does not prevent ventilator-induced lung injury. PLoS One, 5:e15653. 2010.
103.
HelmyKY, PatelSA, SilverioK, PlinerL, RameshwarP. Stem cells and regenerative medicine: accomplishments to date and future promise. Ther Deliv, 1:693–705. 2010.
HongKU, ReynoldsSD, GiangrecoA, HurleyCM, StrippBR. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol, 24:671–681. 2001.
107.
HongKU, ReynoldsSD, WatkinsS, FuchsE, StrippBR. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol, 164:577–588. 2004.
108.
HorwitzEM, ProckopDJ, FitzpatrickLA, KooWW, GordonPL, NeelM, SussmanM, OrchardP, MarxJC, PyeritzRE, BrennerMK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med, 5:309–313. 1999.
109.
IonescuLI, AlphonseRS, ArizmendiN, MorganB, AbelM, EatonF, DuszykM, VliagoftisH, AprahamianTR, WalshK, ThebaudB. Airway delivery of soluble factors from plastic-adherent bone marrow cells prevents murine asthma. Am J Respir Cell Mol Biol, 46:207–216. 2012.
110.
IrwinD, HelmK, CampbellN, ImamuraM, FaganK, HarralJ, CarrM, YoungKA, KlemmD, GebbS, DempseyEC, WestJ, MajkaS. Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification. Am J Physiol Lung Cell Mol Physiol, 293:L941–L951. 2007.
111.
IshizawaK, KuboH, YamadaM, KobayashiS, SuzukiT, MizunoS, NakamuraT, SasakiH. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun, 324:276–280. 2004.
112.
IyerSS, Torres-GonzalezE, NeujahrDC, KwonM, BrighamKL, JonesDP, MoraAL, RojasM. Effect of bone marrow-derived mesenchymal stem cells on endotoxin-induced oxidation of plasma cysteine and glutathione in mice. Stem Cells Int, 2010:868076. 2010.
113.
JakkulaM, Le CrasTD, GebbS, HirthKP, TuderRM, VoelkelNF, AbmanSH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol, 279:L600–L607. 2000.
114.
JamesML, RossAC, BulgerA, PhilipsJB3rd, AmbalavananN. Vitamin A and retinoic acid act synergistically to increase lung retinyl esters during normoxia and reduce hyperoxic lung injury in newborn mice. Pediatr Res, 67:591–597. 2010.
115.
JanerJ, AnderssonS, HaglundC, LassusP. Pulmonary endostatin perinatally and in lung injury of the newborn infant. Pediatrics, 119:e241–e246. 2007.
116.
JanerJ, AnderssonS, KajantieE, LassusP. Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants. Pediatrics, 123:1142–1146. 2009.
117.
JankovRP, NegusA, TanswellAK. Antioxidants as therapy in the newborn: some words of caution. Pediatr Res, 50:681–687. 2001.
Kanki-HorimotoS, HorimotoH, MienoS, KishidaK, WatanabeF, FuruyaE, KatsumataT. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation, 114:I181–I185. 2006.
123.
KatshaAM, OhkouchiS, XinH, KanehiraM, SunR, NukiwaT, SaijoY. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther J Am Soc Gene Ther, 19:196–203. 2011.
124.
KiddS, SpaethE, KloppA, AndreeffM, HallB, MariniFC. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy, 10:657–667. 2008.
125.
KimCB. Advancing the field of lung stem cell biology. Front Biosci, 12:3117–3124. 2007.
126.
KimCFB, JacksonEL, WoolfendenAE, LawrenceS, BabarI, VogelS, CrowleyD, BronsonRT, JacksT. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 121:823–835. 2005.
127.
KimDH, ChoiCW, KimEK, KimHS, KimBI, ChoiJH, LeeMJ, YangEG. Association of increased pulmonary interleukin-6 with the priming effect of intra-amniotic lipopolysaccharide on hyperoxic lung injury in a rat model of bronchopulmonary dysplasia. Neonatology, 98:23–32. 2010.
128.
KinsellaJP, CutterGR, WalshWF, GerstmannDR, BoseCL, HartC, SekarKC, AutenRL, BhutaniVK, GerdesJS, GeorgeTN, SouthgateWM, CarriedoH, CouserRJ, MammelMC, HallDC, PappagalloM, SardesaiS, StrainJD, BaierM, AbmanSH. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med, 355:354–364. 2006.
KooHC, DavisJM, LiY, HatzisD, OpsimosH, PollackS, StrayerMS, BallardPL, KazzazJA. Effects of transgene expression of superoxide dismutase and glutathione peroxidase on pulmonary epithelial cell growth in hyperoxia. Am J Physiol Lung Cell Mol Physiol, 288:L718–L726. 2005.
131.
KotechaS, WangooA, SilvermanM, ShawRJ. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr, 128:464–469. 1996.
132.
KovacicJC, BoehmM. Resident vascular progenitor cells: an emerging role for non-terminally differentiated vessel-resident cells in vascular biology. Stem Cell Res, 2:2–15. 2009.
133.
KrasnodembskayaA, SongY, FangX, GuptaN, SerikovV, LeeJW, MatthayMA. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells, 28:2229–2238. 2010.
134.
KrauseDS, TheiseND, CollectorMI, HenegariuO, HwangS, GardnerR, NeutzelS, SharkisSJ. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell, 105:369–377. 2001.
135.
KugathasanL, RayJB, DengY, RezaeiE, DumontDJ, StewartDJ. The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice. J Exp Med, 206:2221–2234. 2009.
KunigAM, BalasubramaniamV, MarkhamNE, MorganD, MontgomeryG, GroverTR, AbmanSH. Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol, 289:L529–L535. 2005.
138.
LadhaF, BonnetS, EatonF, HashimotoK, KorbuttG, ThebaudB. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med, 172:750–756. 2005.
139.
Le BlancK, RasmussonI, SundbergB, GötherströmC, HassanM, UzunelM, RingdénO. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363:1439–1441. 2004.
140.
Le CrasTD, MarkhamNE, TuderRM, VoelkelNF, AbmanSH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol, 283:L555–L562. 2002.
141.
Le CrasTD, SpitzmillerRE, AlbertineKH, GreenbergJM, WhitsettJA, AkesonAL. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol, 287:L134–L142. 2004.
142.
LeeHJ, ChoiCW, KimBI, KimEK, KimHS, ChoiJH, LeeMJ, YangEG. Serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia induced by intra-amniotic lipopolysaccharide and postnatal hyperoxia. J Perinat Med, 38:675–681. 2010.
143.
LeeJW, GuptaN, SerikovV, MatthayMA. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther, 9:1259–1270. 2009.
144.
LeuwerkeSM, KazaAK, TribbleCG, KronIL, LaubachVE. Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol, 282:L1272–L1278. 2002.
145.
LevisJ, LoiR, ButnorKJ, VacekP, SteeleC, MossmanBT, WeissDJ. Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant. Am J Respir Cell Mol Biol, 38:16–25. 2008.
146.
LiDY, BrookeB, DavisEC, MechamRP, SorensenLK, BoakBB, EichwaldE, KeatingMT. Elastin is an essential determinant of arterial morphogenesis. Nature, 393:276–280. 1998.
147.
LieblerJM, LutzkoC, BanfalviA, SenadheeraD, AghamohammadiN, CrandallED, BorokZ. Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol, 295:L285–L292. 2008.
148.
LinY, HoganWJ. Clinical application of mesenchymal stem cells in the treatment and prevention of graft-versus-host disease. Adv Hematol, 2011:427863. 2011.
149.
LinYJ, MarkhamNE, BalasubramaniamV, TangJR, MaxeyA, KinsellaJP, AbmanSH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res, 58:22–29. 2005.
150.
LindahlP, KarlssonL, HellströmM, Gebre-MedhinS, WillettsK, HeathJK, BetsholtzC. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development, 124:3943–3953. 1997.
151.
LingT-Y, KuoM-D, LiC-L, YuAL, HuangY-H, WuT-J, LinY-C, ChenS-H, YuJ. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A, 103:9530–9535. 2006.
152.
LiuC, MorriseyEE, WhitsettJA. GATA-6 is required for maturation of the lung in late gestation. Am J Physiol Lung Cell Mol Physiol, 283:L468–L475. 2002.
153.
LiuH, ChangL, RongZ, ZhuH, ZhangQ, ChenH, LiW. Association of insulin-like growth factors with lung development in neonatal rats. J Huazhong Univ Sci Technol Med Sci, 24:162–165. 2004.
154.
LoiR, BeckettT, GonczKK, SurattBT, WeissDJ. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med, 173:171–179. 2006.
155.
LuoX, SedlackovaL, BelcastroR, CabacunganJ, LyeSJ, TanswellAK. Effect of the 21-aminosteroid U74389G on oxygen-induced free radical production, lipid peroxidation, and inhibition of lung growth in neonatal rats. Pediatr Res, 46:215–223. 1999.
156.
MajkaSM, BeutzMA, HagenM, IzzoAA, VoelkelN, HelmKM. Identification of novel resident pulmonary stem cells: form and function of the lung side population. Stem Cells, 23:1073–1081. 2005.
157.
MalgieriA, KantzariE, PatriziMP, GambardellaS. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med, 3:248–269. 2010.
158.
ManiscalcoWM, WatkinsRH, RoperJM, StaverskyR, O'ReillyMA. Hyperoxic ventilated premature baboons have increased p53, oxidant DNA damage and decreased VEGF expression. Pediatr Res, 58:549–556. 2005.
159.
MasonRJ. Biology of alveolar type II cells. Respirology 11, Suppl:S12–S15. 2006.
160.
MasoodA, YiM, LauM, BelcastroR, ShekS, PanJ, KantoresC, McNamaraPJ, KavanaghBP, BelikJ, JankovRP, TanswellAK. Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats. Am J Physiol Lung Cell Mol Physiol, 297:L920–L930. 2009.
161.
MatthayMA, ThompsonBT, ReadEJ, McKennaDH, LiuKD, CalfeeCS, LeeJW. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest, 138:965–972. 2010.
162.
McCarterSD, MeiSH, LaiPF, ZhangQW, ParkerCH, SuenRS, HoodRD, ZhaoYD, DengY, HanRN, DumontDJ, StewartDJ. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med, 175:1014–1026. 2007.
163.
McCurninDC, PierceRA, ChangLY, GibsonLL, Osborne-LawrenceS, YoderBA, KerecmanJD, AlbertineKH, WinterVT, CoalsonJJ, CrapoJD, GrubbPH, ShaulPW. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol, 288:L450–L459. 2005.
McQualterJL, BrouardN, WilliamsB, BairdBN, Sims-LucasS, YuenK, NilssonSK, SimmonsPJ, BertoncelloI. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells, 27:623–633. 2009.
166.
McQualterJL, YuenK, WilliamsB, BertoncelloI. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci U S A, 107:1414–1419. 2010.
167.
MeiSHJ, McCarterSD, DengY, ParkerCH, LilesWC, StewartDJ. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med, 4:e269. 2007.
168.
MercierJC, HummlerH, DurrmeyerX, Sanchez-LunaM, CarnielliV, FieldD, GreenoughA, Van OvermeireB, JonssonB, HallmanM, BaldassarreJ. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Lancet, 376:346–354. 2010.
169.
MetzgerRJ, KleinOD, MartinGR, KrasnowMA. The branching programme of mouse lung development. Nature, 453:745–750. 2008.
170.
MetzgerRJ, KrasnowMA. Genetic control of branching morphogenesis. Science, 284:1635–1639. 1999.
171.
MoodleyY, AtienzaD, ManuelpillaiU, SamuelCS, TchongueJ, IlancheranS, BoydR, TrounsonA. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol, 175:303–313. 2009.
172.
MooreBB, KolodsickJE, ThannickalVJ, CookeK, MooreTA, HogaboamC, WilkeCA, ToewsGB. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol, 166:675–684. 2005.
173.
MyersTJ, Granero-MoltoF, LongobardiL, LiT, YanY, SpagnoliA. Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opin Biol Ther, 10:1663–1679. 2010.
174.
NemethK, Keane-MyersA, BrownJM, MetcalfeDD, GorhamJD, GorhamJD, BundocVG, BundocVG, HodgesMG, JelinekI, MadalaS, KarpatiS, MezeyE. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci U S A, 107:5652–5657. 2010.
175.
NémethK, LeelahavanichkulA, YuenPST, MayerB, ParmeleeA, DoiK, RobeyPG, LeelahavanichkulK, KollerBH, BrownJM, HuX, JelinekI, StarRA, MezeyE. Bone marrow stromal cells attenuate sepsis via prostaglandin E (2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med, 15:42–49. 2009.
176.
NeuringerIP, RandellSH. Stem cells and repair of lung injuries. Respir Res, 5:6. 2004.
177.
NielsenHC. Epidermal growth factor influences the developmental clock regulating maturation of the fetal lung fibroblast. Biochim Biophys Acta, 1012:201–206. 1989.
178.
Nolen-WalstonRD, KimCF, MazanMR, IngenitoEP, GruntmanAM, TsaiL, BostonR, WoolfendenAE, JacksT, HoffmanAM. Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am J Physiol Lung Cell Mol Physiol, 294:L1158–L1165. 2008.
179.
NorthwayWHJr., RosanRC, PorterDY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med, 276:357–368. 1967.
180.
OhkiY, MayuzumiH, TokuyamaK, YoshizawaY, ArakawaH, MochizukiH, MorikawaA. Hepatocyte growth factor treatment improves alveolarization in a newborn murine model of bronchopulmonary dysplasia. Neonatology, 95:332–338. 2009.
181.
OrtizLA, DutreilM, FattmanC, PandeyAC, TorresG, GoK, PhinneyDG. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A, 104:11002–11007. 2007.
182.
PanL, FuJH, XueXD, XuW, ZhouP, WeiB. Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia. World J Pediatr, 5:216–221. 2009.
183.
PapapetropoulosA, Garcia-CardenaG, MadriJA, SessaWC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest, 100:3131–3139. 1997.
PasqualiMA, GelainDP, OliveiraMR, BehrGA, MottaLL, RochaRF, KlamtF, MoreiraJC. Vitamin A supplementation induces oxidative stress and decreases the immunocontent of catalase and superoxide dismutase in rat lungs. Exp Lung Res, 35:427–438. 2009.
186.
PerroneS, TatarannoML, NegroS, LonginiM, MarzocchiB, ProiettiF, IacoponiF, CapitaniS, BuonocoreG. Early identification of the risk for free radical-related diseases in preterm newborns. Early Hum Dev, 86:241–244. 2010.
187.
PhillipsRJ, BurdickMD, HongK, LutzMA, MurrayLA, XueYY, BelperioJA, KeaneMP, StrieterRM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest, 114:438–446. 2004.
PopovaAP, BozykPD, GoldsmithAM, LinnMJ, LeiJ, BentleyJK, HershensonMB. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol, 298:L735–L743. 2010.
192.
PowersHJ, LobanA, SilversK, GibsonAT. Vitamin C at concentrations observed in premature babies inhibits the ferroxidase activity of caeruloplasmin. Free Radic Res, 22:57–65. 1995.
193.
PraterDN, CaseJ, IngramDA, YoderMC. Working hypothesis to redefine endothelial progenitor cells. Leukemia, 21:1141–1149. 2007.
194.
PurevdorjE, ZscheppangK, HoymannHG, BraunA, von MayersbachD, BrinkhausMJ, SchmiedlA, DammannCE. ErbB4 deletion leads to changes in lung function and structure similar to bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol, 294:L516–L522. 2008.
195.
Quintos-AlaghebandML, WhiteCW, SchwarzMA. Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia. Antioxid Redox Signal, 6:137–145. 2004.
196.
RamirezMI, MillienG, HindsA, CaoY, SeldinDC, WilliamsMC. T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol, 256:61–72. 2003.
197.
RamsayPL, DeMayoFJ, HegemierSE, WeardenME, SmithCV, WeltySE. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med, 164:155–161. 2001.
198.
RaoulW, Wagner-BallonO, SaberG, HulinA, MarcosE, GiraudierS, VainchenkerW, AdnotS, EddahibiS, MaitreB. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice. Respir Res, 8:8. 2007.
199.
RawlinsEL, ClarkCP, XueY, HoganBLM. The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development, 136:3741–3745. 2009.
200.
RawlinsEL, HoganBLM. Epithelial stem cells of the lung: privileged few or opportunities for many?Development, 133:2455–2465. 2006.
201.
RawlinsEL, OkuboT, XueY, BrassDM, AutenRL, HasegawaH, WangF, HoganBLM. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell, 4:525–534. 2009.
202.
ReddyR, BuckleyS, DoerkenM, BarskyL, WeinbergK, AndersonKD, WarburtonD, DriscollB. Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am J Physiol Lung Cell Mol Physiol, 286:L658–L667. 2004.
203.
ReynoldsSD, ShenH, ReynoldsPR, BetsuyakuT, PilewskiJM, GambelliF, Di GiuseppeM, OrtizLA, StrippBR. Molecular and functional properties of lung SP cells. Am J Physiol Lung Cell Mol Physiol, 292:L972–L983. 2007.
204.
RibattiD. Endogenous inhibitors of angiogenesis: a historical review. Leuk Res, 33:638–644. 2009.
205.
RockJR, RandellSH, HoganBLM. Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech, 3:545–556. 2010.
206.
RojasM, XuJ, WoodsCR, MoraAL, SpearsW, RomanJ, BrighamKL. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol, 33:145–152. 2005.
207.
RojasMA, GonzalezA, BancalariE, ClaureN, PooleC, Silva-NetoG. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr, 126:605–610. 1995.
208.
Roth-KleinerM, PostM. Similarities and dissimilarities of branching and septation during lung development. Pediatr Pulmonol, 40:113–134. 2005.
209.
RotruckJT, PopeAL, GantherHE, SwansonAB, HafemanDG, HoekstraWG. Selenium: biochemical role as a component of glutathione peroxidase. Science, 179:588–590. 1973.
210.
SaugstadOD. Optimal oxygenation at birth and in the neonatal period. Neonatology, 91:319–322. 2007.
211.
SaugstadOD. Oxygen and oxidative stress in bronchopulmonary dysplasia. J Perinat Med, 38:571–577. 2010.
212.
SchipaniE, KronenbergHM. Adult mesenchymal stem cellsStemBook. Cambridge, MA: Harvard Stem Cell Institute, 2008. www.ncbi.nlm.nih.gov/pubmed/20614616[cited 2012 Mar 30].
213.
SchmiedlA, BehrensJ, ZscheppangK, PurevdorjE, von MayersbachD, LieseA, DammannCE. Lipopolysaccharide-induced injury is more pronounced in fetal transgenic ErbB4-deleted lungs. Am J Physiol Lung Cell Mol Physiol, 301:L490–L499. 2011.
214.
SchreiberMD, Gin-MestanK, MarksJD, HuoD, LeeG, SrisuparpP. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med, 349:2099–2107. 2003.
215.
SchultzCJ, TorresE, LondosC, TordayJS. Role of adipocyte differentiation-related protein in surfactant phospholipid synthesis by type II cells. Am J Physiol Lung Cell Mol Physiol, 283:L288–L296. 2002.
216.
SchwarzM, LeeM, ZhangF, ZhaoJ, JinY, SmithS, BhuvaJ, SternD, WarburtonD, StarnesV. EMAP II: a modulator of neovascularization in the developing lung. Am J Physiol, 276:L365–L375. 1999.
217.
SessaWC. Molecular control of blood flow and angiogenesis: role of nitric oxide. J Thromb Haemost, 7,Suppl 1:35–37. 2009.
218.
ShiW, XuJ, WarburtonD. Development, repair and fibrosis: what is common and why it matters. Respirology, 14:656–665. 2009.
219.
ShigemuraN, OkumuraM, MizunoS, ImanishiY, MatsuyamaA, ShionoH, NakamuraT, SawaY. Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema. Am J Respir Crit Care Med, 174:1199–1205. 2006.
SnyderJC, TeisanuRM, StrippBR. Endogenous lung stem cells and contribution to disease. J Pathol, 217:254–264. 2009.
222.
StahlW, SiesH. Antioxidant defense: vitamins E and C and carotenoids. Diabetes 46 Suppl, 2:S14–S18. 1997.
223.
StenmarkKR, AbmanSH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol, 67:623–661. 2005.
224.
StensonB, BrocklehurstP, Tarnow-MordiW. Increased 36-week survival with high oxygen saturation target in extremely preterm infants. N Engl J Med, 364:1680–1682. 2011.
225.
StevensonK, McGlynnL, ShielsPG. Stem cells: outstanding potential and outstanding questions. Scott Med J, 54:35–37. 2009.
226.
StoneKC, MercerRR, GehrP, StockstillB, CrapoJD. Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol, 6:235–243. 1992.
227.
StrippBR. Hierarchical organization of lung progenitor cells: is there an adult lung tissue stem cell?Proc Am Thorac Soc, 5:695–698. 2008.
228.
SueblinvongV, WeissDJ. Stem cells and cell therapy approaches in lung biology and diseases. Transl Res, 156:188–205. 2010.
229.
SummerR, KottonDN, SunX, MaB, FitzsimmonsK, FineA. Side population cells and Bcrp1 expression in lung. Am J Physiol Lung Cell Mol Physiol, 285:L97–L104. 2003.
230.
TakahashiK, YamanakaS. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676. 2006.
231.
TakahashiM, NakamuraT, TobaT, KajiwaraN, KatoH, ShimizuY. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng, 10:771–779. 2004.
232.
TangJR, MarkhamNE, LinYJ, McMurtryIF, MaxeyA, KinsellaJP, AbmanSH. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol, 287:L344–L351. 2004.
233.
ter HorstSA, FijlstraM, SenguptaS, WaltherFJ, WagenaarGT. Spatial and temporal expression of surfactant proteins in hyperoxia-induced neonatal rat lung injury. BMC Pulm Med, 6:8. 2006.
234.
ThebaudB, AbmanSH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med, 175:978–985. 2007.
235.
ThebaudB, LadhaF, MichelakisED, SawickaM, ThurstonG, EatonF, HashimotoK, HarryG, HaromyA, KorbuttG, ArcherSL. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation, 112:2477–2486. 2005.
236.
ThomasM, AugustinHG. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis, 12:125–137. 2009.
237.
ThomasW, SeidenspinnerS, KramerBW, Kawczynska-LedaN, Chmielnicka-KopaczykM, MarxA, WirbelauerJ, SzymankiewiczM, SpeerCP. Airway concentrations of angiopoietin-1 and endostatin in ventilated extremely premature infants are decreased after funisitis and unbalanced with bronchopulmonary dysplasia/death. Pediatr Res, 65:468–473. 2009.
238.
ThurstonG. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat, 200:575–580. 2002.
239.
TillJE, MccullochEA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res, 14:213–222. 1961.
240.
TinW. Optimal oxygen saturation for preterm babies. Do we really know?Biol Neonate, 85:319–325. 2004.
241.
TögelF, HuZ, WeissK, IsaacJ, LangeC, WestenfelderC. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol, 289:F31–F42. 2005.
242.
TordayJS, RehanVK. Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res, 62:2–7. 2007.
243.
TourneuxP, MarkhamN, SeedorfG, BalasubramaniamV, AbmanSH. Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats. Am J Physiol Lung Cell Mol Physiol, 297:L1103–L1111. 2009.
244.
TysonJE, WrightLL, OhW, KennedyKA, MeleL, EhrenkranzRA, StollBJ, LemonsJA, StevensonDK, BauerCR, KoronesSB, FanaroffAA. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med, 340:1962–1968. 1999.
245.
UlichTR, YiES, LongmuirK, YinS, BiltzR, MorrisCF, HousleyRM, PierceGF. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest, 93:1298–1306. 1994.
246.
UmarS, de VisserYP, SteendijkP, SchutteCI, LaghmaniEH, WagenaarGTM, BaxWH, MantikouE, PijnappelsDA, AtsmaDE, SchalijMJ, van der WallEE, van der LaarseA. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol, 297:H1606–H1616. 2009.
247.
van der HeijdenM, van Nieuw AmerongenGP, ChedamniS, van HinsberghVW, Johan GroeneveldAB. The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury. Expert Opin Ther Targets, 13:39–53. 2009.
248.
van HaaftenT, ByrneR, BonnetS, RochefortGY, AkabutuJ, BouchentoufM, Rey-ParraGJ, GalipeauJ, HaromyA, EatonF, ChenM, HashimotoK, AbleyD, KorbuttG, ArcherSL, ThébaudB. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med, 180:1131–1142. 2009.
Veness-MeehanKA, BottoneFGJr., StilesAD. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats. Pediatr Res, 48:434–444. 2000.
251.
VicencioAG, LeeCG, ChoSJ, EickelbergO, ChuuY, HaddadGG, EliasJA. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia?Am J Respir Cell Mol Biol, 31:650–656. 2004.
252.
This reference has been deleted.
253.
VosdoganesP, HodgesRJ, LimR, WestoverAJ, AcharyaRY, WallaceEM, MossTJ. Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. Am J Obstet Gynecol, 205:156e26–156 e33. 2011.
254.
VozzelliMA, MasonSN, WhortonMH, AutenRLJr.Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. Am J Physiol Lung Cell Mol Physiol, 286:L488–L493. 2004.
255.
WagenaarGT, ter HorstSA, van GastelenMA, LeijserLM, MauadT, van der VeldenPA, de HeerE, HiemstraPS, PoorthuisBJ, WaltherFJ. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Biol Med, 36:782–801. 2004.
256.
WanH, XuY, IkegamiM, StahlmanMT, KaestnerKH, AngS-L, WhitsettJA. Foxa2 is required for transition to air breathing at birth. Proc Natl Acad Sci U S A, 101:14449–14454. 2004.
257.
WangD, MoralesJE, CalameDG, AlcornJL, WetselRA. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther, 18:625–634. 2010.
258.
WattFM, HoganBL. Out of Eden: stem cells and their niches. Science, 287:1427–1430. 2000.
259.
WendelDP, TaylorDG, AlbertineKH, KeatingMT, LiDY. Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol, 23:320–326. 2000.
260.
WongPM, LeesAN, LouwJ, LeeFY, FrenchN, GainK, MurrayCP, WilsonA, ChambersDC. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J, 32:321–328. 2008.
261.
XuJ, QuJ, CaoL, SaiY, ChenC, HeL, YuL. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol, 214:472–481. 2008.
262.
XuJ, WoodsCR, MoraAL, JoodiR, BrighamKL, IyerS, RojasM. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol, 293:L131–L141. 2007.
263.
YagiH, Soto-GutierrezA, KitagawaY, TillesAW, TompkinsRG, YarmushML. Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant, 19:823–830. 2010.
ZhaoYD, CourtmanDW, DengY, KugathasanL, ZhangQ, StewartDJ. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res, 96:442–450. 2005.
270.
ZhenG, LiuH, GuN, ZhangH, XuY, ZhangZ. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci, 13:3415–3422. 2008.
